Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:43 PM
Ignite Modification Date:
2025-12-24 @ 5:43 PM
NCT ID:
NCT03453268
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients aged 80 and over
* Patients living in nursing homes
* Patients with a SBP \< 130 mmHg measured in Medical-Social Institutions using the connected blood pressure monitor supplied for the study (average of the last 2 out of 3 measurements after 10 min rest)
* Hypertensive patients whose treatment contains at least 2 antihypertensive molecules and whose treatment has been stabilised for at least :
* 3 weeks in the case of the introduction or discontinuation of an anti-HBP drug
* 2 weeks in the case of a change in the dosage of one of the anti-HBP drugs.
* Patients affiliated to a social security scheme
* Patients who have signed the informed consent form (failing which, the legal representative)
* Patients with dementia or with a severe reduction in physical function (impaired vision, asthenia, advanced osteoarthritis, severe tremors, etc.) and/or cognitive function may be included in this study with the agreement of their carers or family/relatives.
Exclusion Criteria:
* Patients in whom no antihypertensive molecule can be reduced for specific reasons (heart failure with ejection fraction \<40%, fluid retention due to heart failure, coronary artery disease and diabetic nephropathy).
* Patients with an estimated life expectancy of \<3 months
* Patients who have already been included in this study or in another study at the same time
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
80 Years
Study:
NCT03453268
Study Brief:
Protocol Section:
NCT03453268